Novel MCH receptor antagonists

Details for Australian Patent Application No. 2007257845 (hide)

Owner Eli Lilly and Company

Inventors Gardinier, Kevin Matthew; Garmene, David Joseph; Lu, Jianliang; Spinazze, Patrick Gianpietro; Hembre, Erik James; Dao, Yen; Green, Steven James; Amegadzie, Albert Kudzovi

Agent Spruson & Ferguson

Pub. Number AU-A-2007257845

PCT Pub. Number WO2007/146759

Priority 60/811,838 08.06.06 US

Filing date 8 June 2007

Wipo publication date 21 December 2007

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/146759 Priority application(s): WO2007/146759

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257848-System and method for continuously offered guaranteed mutual fund with full and permanent allocation to risky markets investments

2007257841-Substituted phenyl acetic acids as DP-2 antagonists